2018
DOI: 10.1016/j.tim.2018.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Towards Understanding MCR-like Colistin Resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
361
0
7

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 384 publications
(391 citation statements)
references
References 137 publications
11
361
0
7
Order By: Relevance
“…Colistin was considered one of the last lines of defense against lethal CRE infections 1–5. Unfortunately, many species of Enterobacteriaceae are becoming increasingly resistant to colistin 2,4,6,7. One colistin resistant mechanism is the modification of Lipid A of LPS, catalyzed by the chromosome encoded machinery in Klebsiella pneumoniae , the LptA (EptA) in Neisseria , or mobile colistin resistance mcr‐1 in Enterobacteriaceae 5,8–11.…”
Section: Introductionmentioning
confidence: 99%
“…Colistin was considered one of the last lines of defense against lethal CRE infections 1–5. Unfortunately, many species of Enterobacteriaceae are becoming increasingly resistant to colistin 2,4,6,7. One colistin resistant mechanism is the modification of Lipid A of LPS, catalyzed by the chromosome encoded machinery in Klebsiella pneumoniae , the LptA (EptA) in Neisseria , or mobile colistin resistance mcr‐1 in Enterobacteriaceae 5,8–11.…”
Section: Introductionmentioning
confidence: 99%
“…In general, carbapenems are used as a last line of defense antibiotics against severe infections with MDR-possessing Enteriobactericeae. Colistin, a cationic antimicrobial polypeptide, is clinically regarded as a final line of defense to treat lethal challenges with carbapenem-resistant pathogens [4,5]. Unfortunately, it seems likely that the clinical use of carbapenems and colistin has been significantly challenged by the occurrence of mobilized colistin resistance determinant (MCR-1) in clinical carbapenem-resistant isolates producing New Delhi metallo- β -lactamase 1 (NDM-1) [6,7] or its variant NDM-5 [8,9].…”
mentioning
confidence: 99%
“…Unfortunately, it seems likely that the clinical use of carbapenems and colistin has been significantly challenged by the occurrence of mobilized colistin resistance determinant (MCR-1) in clinical carbapenem-resistant isolates producing New Delhi metallo- β -lactamase 1 (NDM-1) [6,7] or its variant NDM-5 [8,9]. In addition to the intrinsic determinants of colistin resistance (e.g., EptA [10,11] and ICR-Mo [12]), the transferable determinants (MCR-1 and MCR-2 [10,13,14]) consistently encode members of phosphoethanolamine (PEA)-lipid A transferases, which adopt a ‘ping-pong’ catalysis reaction in transferring of the PEA moiety to the 4ʹ-phosphate position of the lipopolysaccharide (LPS)-lipid A species anchored on bacterial surface [4,5]. …”
mentioning
confidence: 99%
“…The mcr ‐1 resistance gene is found on a highly transmissible plasmid, namely IncX 4 which is a narrow host range mobile element of Enterobacteriaceae with a lack of fitness burden on bacterial host (Liu et al , ). Recent evidence strongly suggests transfer of mcr ‐1 from animals to humans while it also can be spread in hospitals without colistin pressure (Paterson and Harris, ; Al‐Tawfiq et al , ; references therein Sun et al , ). Subsequently, mcr ‐2, another plasmid‐mediated colistin resistance gene, has been identified in porcine and bovine colistin‐resistant E. coli (Xavier et al , ).…”
Section: Discussionmentioning
confidence: 99%